NCT05824637

Brief Summary

To improve accuracy and take out human error opportunities, Hippo Dx developed S.P.A.T., an automated skin prick test. This study will provide a comparison between manual and automated skin prick test in allergic and non-allergic individuals with a panel of common inhalant allergens. The primary endpoint is to compare the accuracy of S.P.A.T. to detect sensitization to common aeroallergens compared to a manual skin prick test (SPT). It is a prospective monocentric study that will include 120 study participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

March 18, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 21, 2023

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

February 28, 2024

Status Verified

July 1, 2023

Enrollment Period

1 month

First QC Date

January 30, 2023

Last Update Submit

February 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Within-test agreement (% of patients with consistent results) of wheal positivity per allergen between manual and automated test.

    Each of the allergens are pricked three times via manual and automated skin prick test. Three positive or negative test results are considered consistent whereas either one or two positive or negative test results are considered non-consistent resulting in an inconclusive test result.

    15 minutes after the diagnostic test

Secondary Outcomes (4)

  • Allergy symptoms assessed by visual analogue scale between patients with a positive versus negative test result.

    day of the diagnostic test

  • Time (seconds) required to run an automated versus a manual skin prick test.

    during the diagnostic test

  • Amount of allergen solution that is required to run an automated versus a manual skin prick test.

    during the diagnostic test

  • Level of discomfort experienced by the patient as assessed by visual analogue scale after an automated versus a manual skin prick test.

    15 minutes after the diagnostic test

Study Arms (1)

Skin Prick Test

OTHER

Study participants will receive a skin prick test by the skin prick automated test device on the right arm and manually by a health care provider on the left arm.

Device: Skin Prick Automated TestDiagnostic Test: Skin Prick Manual Test

Interventions

skin prick test to detection sensitisation to aeroallergens

Skin Prick Test
Skin Prick Manual TestDIAGNOSTIC_TEST

skin prick test to detection sensitisation to aeroallergens

Skin Prick Test

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (18-65y) with presence or absence of self-reported symptoms of inhalant allergy will be included.

You may not qualify if:

  • Skin pathology like chronic or exuberant urticaria, dermographism, chronic dermatitis that needs daily treatment
  • Use of antihistaminic medication \< 7 days before the start of the study
  • Use of tricyclic antidepressants (antihistamine activity) \< 7 days before the start of the study
  • Use of topical corticoids on the forearm \< 7 days before the start of the study
  • Use of Omalizumab \< 6 months before the start of the study
  • Pregnancy: there is a remote possibility of inducing a systemic allergic reaction that could induce uterine contractions or necessitate the use of epinephrine (thought to cause constriction of the umbilical artery)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AZ Herentals

Herentals, 2200, Belgium

Location

MeSH Terms

Conditions

Rhinitis, Allergic, Seasonal

Condition Hierarchy (Ancestors)

Rhinitis, AllergicRhinitisNose DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityOtorhinolaryngologic DiseasesHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Hendrik Sebrechts, MD

    AZ Herentals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2023

First Posted

April 21, 2023

Study Start

March 18, 2023

Primary Completion

April 30, 2023

Study Completion

June 30, 2023

Last Updated

February 28, 2024

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations